Sleep spindles in Parkinson's disease may predict the development of dementia

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 1083-1090

  Latreille, Véronique ^a,b   Carrier, Julie ^a,b   Lafortune, Marjolaine ^a,b   Postuma, Ronald B ^a,c   Bertrand, Josie Anne ^a,d   Panisset, Michel ^e   Chouinard, Sylvain ^e   Gagnon, Jean François ^a,d  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cognition; Dementia; Electroencephalography; Non rapid eye movement sleep; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONREM SLEEP; OCCIPITAL LOBE; PARIETAL LOBE; PARKINSON DISEASE; POLYSOMNOGRAPHY; SENSITIVITY AND SPECIFICITY; SLEEP SPINDLE; SLOW WAVE SLEEP; BRAIN; BRAIN CORTEX; COMPLICATION; ELECTROENCEPHALOGRAM; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY; REM SLEEP; SLEEP; SLEEP WAKE DISORDERS;

AGED; BRAIN; BRAIN WAVES; CEREBRAL CORTEX; DEMENTIA; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONAL PLASTICITY; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; SLEEP; SLEEP WAKE DISORDERS; SLEEP, REM;

EID: 84922947243     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.09.009     Document Type: Article

References (60)

1. Aarsland D., Kurz M.W. The epidemiology of dementia associated with Parkinson's disease. Brain Pathol. 2010, 20:633-639.
2. The International Classification of Sleep Disorders: Diagnostic and Coding Manual 2005, American Academy of Sleep Medicine, Task Force Chair, American Academy of Sleep Medicine, Westchester IL. second ed. P.J. Hauri (Ed.).
3. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Text Revised, American Psychiatric Press, Washington DC. Fourth ed.
4. Balaid H., Adrien J., Laffrat E., Tandé D., Karachi C., Grabli D., Arnulf I., Clark S.D., Drouot E.C., François C. Sleep disorders in Parkinsonian macaques: effects of L-Dopa treatment and pedunculopontine nucleus lesion. J.Neurosci. 2014, 34:9124-9133.
5. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J.Consult Clin. Psychol. 1988, 56:893-897.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
7. Bohnen N.I., Albin R.L. The cholinergic system and Parkinson disease. Behav. Brain Res. 2011, 221:564-573.
8. Brunner D.P., Vasko R.C., Detka C.S., Monahan J.P., Reynolds C.F., Kupfer D.J. Muscle artifacts in the sleep EEG: automated detection and effect on all-night EEG power spectra. J.Sleep Res. 1996, 5:155-164.
9. Brunner H., Wetter T.C., Hogl B., Yassouridis A., Trenkwalder C., Friess E. Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. Mov. Disord. 2002, 17:928-933.
10. Carrier J., Viens I., Poirier G., Robillard R., Lafortune M., Vandewalle G., Martin N., Barakat M., Paquet J., Filipini D. Sleep slow wave changes during the middle years of life. Eur. J. Neurosci. 2011, 33:758-766.
11. Chahine L.M., Daley J., Horn S., Duda J.E., Colcher A., Hurtig H., Cantor C., Dahodwala N. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease. Parkinsonism Relat. Disord. 2013, 19:859-863.
12. Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006, 5:235-245.
13. Chaudhuri K.R., Odin P., Antonini A., Martinez-Martin P. Parkinson's disease: the non-motor issues. Parkinsonism Relat. Disord. 2011, 17:717-723.
14. Christensen J.A., Kempfner J., Zoetmulder M., Leonthin H.L., Arvastson L., Christensen S.R., Sorensen H.B., Jennum P. Decreased sleep spindle density in patients with idiopathic REM sleep behavior disorder and patients with Parkinson's disease. Clin. Neurophysiol. 2014, 125:512-519.
15. Diederich N.J., Paolini V., Vaillant M. Slow wave sleep and dopaminergic treatment in Parkinson's disease: a polysomnographic study. Acta Neurol. Scand. 2009, 120:308-313.
16. Diederich N.J., Rufra O., Pieri V., Hipp G., Vaillant M. Lack of polysomnographic non-REM sleep changes in early Parkinson's disease. Mov. Disord. 2013, 28:1443-1446.
17. Dubois B., Burn D., Goetz C., Aarsland D., Brown R.G., Broe G.A., Dickson D., Duyckaerts C., Cummings J., Gauthier S., Korczyn A., Lees A., Levy R., Litvan I., Mizuno Y., McKeith I.G., Olanow C.W., Poewe W., Sampaio C., Tolosa E., Emre M. Diagnostic procedures for Parkinson's disease dementia: recommendations from the Movement Disorder Society Task Force. Mov. Disord. 2007, 22:2314-2324.
18. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 2009, 32:548-557.
19. Emser W., Brenner M., Stober T., Schimrigk K. Changes in nocturnal sleep in Huntington's and Parkinson's disease. J.Neurol. 1988, 235:177-179.
20. Fahn S., Elton R.L. Members of the unified Parkinson's disease rating scale development committee. Unified Parkinson's disease rating scale. Recent development in Parkinson's disease 1987, Vol 2:153-163. Macmillan Healthcare Information, Florham Park NJ.
21. Feld G.B., Besedovsky L., Kaida K., Münte T.F., Born J. Dopamine D2-like receptor activation wipes out preferential consolidation of high over low reward memories during human sleep. J.Cogn. Neurosci. 2014, 26:2310-2320.
22. Fogel S., Martin N., Lafortune M., Barakat M., Debas K., Laventure S., Latreille V., Gagnon J.F., Doyon J., Carrier J. NREM sleep oscillations and brain plasticity in aging. Front. Neurol. 2012, 3:1-7.
23. Folstein M.F., Folstein S.E., McHugh P.R. ''Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
24. Gagnon J.F., Vendette M., Postuma R.B., Desjardins C., Massicotte-Marquez J., Panisset M., Montplaisir J. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Mov. Disord. 2009, 66:39-47.
25. Garcia-Borreguero D., Caminero A.B., de la Llave Y., Larrosa O., Barrio S., Granizo J.J., Pareja J.A. Decreased phasic EMG activity during rapid eye movement sleep in treatment-naïve Parkinson's disease: effects of treatment with levodopa and progression of illness. Mov. Disord. 2002, 17:934-941.
26. Halliday G.M., Holton J.L., Revesz T., Dickson D.W. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol. 2011, 122:187-204.
27. 123I]ß-CIT SPECT in treated patients with Parkinson's disease. J.Neurol. 2004, 251:1465-1471.
28. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 2008, 23:837-844.
29. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology 1967, 17:427-442.
30. Hornung O.P., Regen F., Dorn H., Anghelescu I., Kathmann N., Schredl M., Danker-Hopfe H., Heuser I. The effects of donepezil on postlearning sleep EEG of healthy older adults. Pharmacopsychiatry 2009, 42:9-13.
31. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J.Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
32. Jellinger K.A. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov. Disord. 2012, 27:8-30.
33. Kaynak D., Kiziltan G., Kaynak H., Benbir G., Uysal O. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur. J. Neurol. 2005, 12:199-207.
34. Kehagia A.A., Barker R., Robbins T.W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol. 2010, 9:1200-1213.
35. Klassen B.T., Hentz J.G., Shill H.A., Driver-Dunckley E., Evidente V.G., Sabbagh M.N., Adler C.H., Caviness J.N. Quantitative EEG as a predictive biomarker for Parkinson disease dementia. Neurology 2011, 77:118-124.
36. Kotagal V., Müller M.L., Kaufer D.I., Koeppe R.A., Bohnen N.I. Thalamic cholinergic innervation is spared in Alzheimer disease compared to Parkinsonian disorders. Neurosci. Lett. 2012, 514:169-172.
37. Lafortune M., Gagnon J.F., Martin N., Latreille V., Dubé J., Bouchard M., Bastien C., Carrier J. Sleep spindles and rapid eye movement sleep as predictors of next morning cognitive performance in healthy middle-aged and older participants. J.Sleep Res. 2014, 23:159-167.
38. Lapierre O., Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992, 42:1371-1374.
39. Latreille V., Carrier J., Montplaisir J., Lafortune M., Gagnon J.F. Non-rapid eye movement sleep characteristics in idiopathic REM sleep behavior disorder. J.Neurol. Sci. 2011, 310:159-162.
40. Litvan I., Goldman J.G., Tröster A.I., Schmand B.A., Weintraub D., Petersen R.C., Mollenhauer B., Adler C.H., Marder K., Williams-Gray C.H., Aarsland D., Kulisevsky J., Rodriguez-Oroz M.C., Burn D.J., Barker R.A., Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines. Mov. Disord. 2012, 27:349-356.
41. Martin N., Lafortune M., Godbout J., Barakat M., Robillard R., Poirier G., Bastien C., Carrier J. Topography of age-related changes in sleep spindles. Neurobiol. Aging 2013, 34:468-476.
42. Menke R.A., Szewczyk-Krolikowski K., Jbabdi S., Jenkinson M., Talbot K., Mackay C.E., Hu M. Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson's disease. Hum. Brain Mapp. 2014, 35:1681-1690.
43. Montplaisir J., Gagnon J.F., Fantini M.L., Postuma R.B., Dauvilliers Y., Desautels A., Rompré S., Paquet J. Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov. Disord. 2010, 25:2044-2051.
44. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J.Am. Geriatr. Soc. 2005, 53:695-699.
45. Olde Dubbelink K.T., Hillebrand A., Twisk J.W., Deijen J.B., Stoffers D., Schmand B.A., Stam C.J., Berendse H.W. Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers. Neurology 2014, 82:263-270.
46. Ozaki A., Nishida M., Koyama K., Ishikawa K., Nishikawa T. Donepezil-induced sleep spindle in a patient with dementia with Lewy bodies: a case report. Psychogeriatrics 2012, 12:255-258.
47. Peeraully T., Yong M.H., Chokroverty S., Tan E.K. Sleep and Parkinson's disease: a review of case-control polysomnography studies. Mov. Disord. 2012, 27:1729-1737.
48. Postuma R.B., Bertrand J.A., Montplaisir J., Desjardins C., Vendette M., Rios Romenets S., Panisset M., Gagnon J.F. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. Mov. Disord. 2012, 27:720-726.
49. Puca F.M., Bricolo A., Turella G. Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism. Electroencephalogr Clin. Neurophysiol. 1973, 35:327-330.
50. Rauchs G., Schabus M., Parapatics S., Bertran F., Clochon P., Hot P., Denise P., Desgranges B., Eustache F., Gruber G., Anderer P. Is there a link between sleep changes and memory in Alzheimer's disease?. Neuroreport 2008, 19:1159-1162.
51. Rechtschaffen A., Kales A.A. AManual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects 1968, US Government Printing Office, Public Health Service, Washington DC.
52. Schabus M., Hödlmoser K., Gruber G., Sauter C., Anderer P., Klösch G., Parapatics S., Saletu B., Klimesch W., Zeitlhofer J. Sleep spindle-related activity in the human EEG and its relation to general cognitive and learning abilities. Eur. J. Neurosci. 2006, 23:1738-1746.
53. Shimada H., Hirano S., Shinotoh H., Aotsuka A., Sato K., Tanaka N., Ota T., Asahina M., Fukushi K., Kuwabara S., Hattori T., Suhara T., Irie T. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 2009, 73:273-278.
54. Sixel-Döring F., Trautmann E., Mollenhauer B., Trenkwalder C. Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease?. Sleep Med. 2012, 13:1178-1183.
55. Steriade M. Grouping of brain rhythms in corticothalamic systems. Neuroscience 2006, 137:1087-1106.
56. Svenningsson P., Westman E., Ballard C., Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 2012, 11:697-707.
57. Wailke S., Herzog J., Witt K., Deuschl G., Volkmann J. Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease. Eur. J. Neurol. 2011, 18:590-596.
58. Westerberg C.E., Mander B.A., Florczak S.M., Weintraub S., Mesulam M.M., Zee P.C., Paller K.A. Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. J.Int. Neuropsychol. Soc. 2012, 18:490-500.
59. Williams-Gray C.H., Evans J.R., Goris A., Foltynie T., Ban M., Robbins T.W., Brayne C., Kolachana B.S., Weinberger D.R., Sawcer S.J., Barker R.A. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009, 132:2958-2969.
60. Ziabreva I., Ballard C.G., Aarsland D., Larsen J.P., McKeith I.G., Perry R.H., Perry E.K. Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiol. Aging 2006, 27:433-438.